Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Experimental Hematology|August 5, 2018
Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesisLane H Miller, Cheng-Kui Qu, Melinda PaulyPediatric Blood & Cancer|February 16, 2016
Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced PancreatitisPatricia Zerra, John Bergsagel, Frank G Keller, et al.Transfusion|February 6, 2018
Hyperleukocytosis in infant acute leukemia: a role for manual exchange transfusion for leukoreductionDaniel V Runco, Cassandra D Josephson, Sunil S Raikar, et al.Nature|November 4, 2016
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironmentLei Dong, Wen-Mei Yu, Hong Zheng, et al.Pediatric Blood & Cancer|October 10, 2022
Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemiaMichael J Burke, David S Ziegler, Francisco Bautista, et al.Blood Advances|June 3, 2026
Carfilzomib plus induction chemotherapy in children with relapsed or refractory acute lymphoblastic leukemiaFranco Locatelli, Musa Karakukcu, Van Huynh, et al.Journal of Pediatric Hematology/Oncology|June 6, 2022
Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation Rescues Marrow Failure From Acute Leukemia Therapy in a Patient With Previously Undiagnosed Ligase IV SyndromeDiana M Fridlyand, Shanmuganathan Chandrakasan, Ahmed Aljudi, et al.Pediatric Blood & Cancer|April 1, 2018
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemiaAndrew E Place, Yana Pikman, Kristen E Stevenson, et al.Cancers|February 10, 2024
Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) ConsortiumAnupam Verma, Yueh-Yun Chi, Jemily Malvar, et al.Nature Communications|October 5, 2023
Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemiaHope Mumme, Beena E Thomas, Swati S Bhasin, et al.Pageof 2